Our platform enables efficient, tunable multiplex gene silencing, modulating multiple targets in one construct for superior safety and potency over traditional editing. Its modular design suits various cell and gene engineering applications.

Cooperation possibilities

Antion leverages its proprietary platform through strategic partnerships, out-licensing of technology and gene constructs, fee-for-service engineering, and customized development, while advancing its R&D pipeline and collaborating with leading technology enablers.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2019
  • Number of employees in Switzerland
    1-9
Core competencies

You may also be interested in